Breast Neoplasms
Showing NaN - NaN of 36
Triple Negative Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III Trial in Boston (Implantable Microdevice (IMD))
Not yet recruiting
- Triple Negative Breast Cancer
- +6 more
- Implantable Microdevice (IMD)
-
Boston, Massachusetts
- +1 more
Mar 8, 2023
Breast Tumors Trial in Worldwide (KU-0059436 (AZD2281) (PARP inhibitor))
Completed
- Breast Neoplasms
- KU-0059436 (AZD2281) (PARP inhibitor)
-
West Hollywood, California
- +16 more
Jan 24, 2023
Breast Cancer, Breast Tumors, Breast Carcinoma Trial in Boston (Breast Cancer Survivor Education Program)
Not yet recruiting
- Breast Cancer
- +3 more
- Breast Cancer Survivor Education Program
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jan 17, 2023
Breast Tumors Trial in Worldwide (Abemaciclib, Fulvestrant, Placebo)
Active, not recruiting
- Breast Neoplasms
- Abemaciclib
- +2 more
-
Fayetteville, Arkansas
- +141 more
Nov 15, 2022
Breast Tumors, Tumor Metastasis Trial in Boston, Canton (CodaLytic)
Not yet recruiting
- Breast Neoplasms
- Neoplasm Metastasis
- CodaLytic
-
Boston, Massachusetts
- +1 more
Oct 28, 2022
Breast Tumors Trial in New Haven, Boston (Dietary/Physical Activity intervention, Usual Care)
Active, not recruiting
- Breast Neoplasms
- Dietary/Physical Activity intervention
- Usual Care
-
New Haven, Connecticut
- +1 more
Oct 4, 2022
Ovarian Tumors, Breast Tumors Trial in Worldwide (Niraparib)
Active, not recruiting
- Ovarian Neoplasms
- Breast Neoplasms
-
Tucson, Arizona
- +22 more
Jul 20, 2022
Breast Tumors Trial in Worldwide (Ipatasertib, Paclitaxel, Placebo)
Breast Tumors, Tumor Metastasis Trial in Puerto Rico, United States (ABI-007 (Abraxane), bevacizumab)
Terminated
- Breast Neoplasms
- Neoplasm Metastasis
- ABI-007 (Abraxane)
- bevacizumab
-
Birmingham, Alabama
- +39 more
Nov 7, 2019
NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)
Terminated
- Carcinoma, Non-Small-Cell Lung
- +7 more
-
Birmingham, Alabama
- +10 more
Jul 17, 2019
Breast Tumors, Pancreatic Tumors Trial in United States (nab-Paclitaxel, Nivolumab, Gemcitabine)
Completed
- Breast Neoplasms
- Pancreatic Neoplasms
- nab-Paclitaxel
- +3 more
-
Sacramento, California
- +14 more
May 29, 2019
Breast Cancer, Breast Tumors, Breast Tumors Trial in Belgium, France, United States (AMG 386 30 mg/kg, Paclitaxel and
Completed
- Breast Cancer
- +9 more
- AMG 386 30 mg/kg, Paclitaxel and Trastuzumab
- +3 more
-
Tucson, Arizona
- +22 more
Apr 2, 2019
Advanced Breast Cancer, Advanced Malignant Solid Tumors, Breast Tumors Trial in Worldwide (HKI-272, Paclitaxel)
Completed
- Advanced Breast Cancer
- +2 more
-
La Jolla, California
- +31 more
Jun 27, 2018
Upstaging of ALH/LCIS Found on Core Biopsy Based on Subsequent
Completed
- Breast Neoplasms
-
Boston, Massachusetts
- +1 more
Mar 30, 2017
Breast Tumors Trial in Boston (Visualization relaxation, Visual Milieu Enhancement (Fine art photograph))
Terminated
- Breast Neoplasms
- Visualization relaxation
- Visual Milieu Enhancement (Fine art photograph)
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Mar 22, 2017
Breast Cancer, Breast Tumors Trial in Spain, United States (XL147 (SAR245408), trastuzumab, paclitaxel)
Completed
- Breast Cancer
- Breast Neoplasms
- XL147 (SAR245408)
- +2 more
-
Los Angeles, California
- +8 more
May 9, 2016